Downregulation of lncRNA TUG1 is involved in ankylosing spondylitis and is related to disease activity and course of treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Downregulation of lncRNA TUG1 is involved in ankylosing spondylitis and is related to disease activity and course of treatment

Published:2018-08-31 Issue:4 Volume:12 Page:389-394
ISSN:1881-7815
Container-title:BioScience Trends
language:en
Short-container-title:BST

Author:

Lan Xiaoyong¹,Ma Haiping²,Zhang Zhiping¹,Ye Dong¹,Min Jun³,Cai Feng¹,Luo Jun⁴

Affiliation:

1. Department of Orthopedics, The Third Affiliated Hospital of Nanchang University

2. Department of Neurosurgery, The Second Affiliated Hospital of Nanchang University

3. Department of Rehabilitation, The Third Affiliated Hospital of Nanchang University

4. Department of Rehabilitation, The Second Affiliated Hospital of Nanchang University

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine,Health(social science)

Link

https://www.jstage.jst.go.jp/article/bst/12/4/12_2018.01117/_pdf

Reference21 articles.

1. 1. Jang JH, Ward MM, Rucker AN, Reveille JD, Davis JC, Jr., Weisman MH, Learch TJ. Ankylosing spondylitis: Patterns of radiographic involvement--a re-examination of accepted principles in a cohort of 769 patients. Radiology. 2011; 258:192-198.

2. 2. Gao X, Wendling D, Botteman MF, Carter JA, Rao S, Cifaldi M. Clinical and economic burden of extra-articular manifestations in ankylosing spondylitis patients treated with anti-tumor necrosis factor agents. J Med Econ. 2012; 15:1054-1063.

3. 3. Kiltz U, van der Heijde D, Mielants H, Feldtkeller E, Braun J, group PEpi. ASAS/EULAR recommendations for the management of ankylosing spondylitis: The patient version. Ann Rheum Dis. 2009; 68:1381-1386.

4. 4. Davis JC, Jr., Van Der Heijde D, Braun J, Dougados M, Cush J, Clegg DO, Kivitz A, Fleischmann R, Inman R, Tsuji W, Enbrel Ankylosing Spondylitis Study G. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial. Arthritis Rheum. 2003; 48:3230-3236.

5. 5. Baeten D, Baraliakos X, Braun J, et al. Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: A randomised, double-blind, placebo-controlled trial. Lancet. 2013; 382:1705-1713.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances of long non-coding RNAs in osteoclast differentiation and osteoporosis;Pathology - Research and Practice;2024-08

2. Xinfeng capsule inhibits lncRNA NONHSAT227927.1/TRAF2 to alleviate NF-κB-p65-induced immuno-inflammation in ankylosing spondylitis;Journal of Ethnopharmacology;2024-04

3. A review of long non-coding RNAs in ankylosing spondylitis: pathogenesis, clinical assessment, and therapeutic targets;Frontiers in Cell and Developmental Biology;2024-03-25

4. Expression of long non‑coding RNA NONHSAT227927.1 and its effect on the JAK2/STAT3 signaling pathway and inflammation in patients with ankylosing spondylitis;Experimental and Therapeutic Medicine;2023-03-31

5. New Insights into the Regulatory Role of Ferroptosis in Ankylosing Spondylitis via Consensus Clustering of Ferroptosis-Related Genes and Weighted Gene Co-Expression Network Analysis;Genes;2022-07-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3